Development of a recombinant CHO cell model for the investigation of CAR and DAF role during early steps of echovirus 6 infection

Virus Research

Volumn 158, Issue 1-2, 2011, Pages 46-54

  Renois, Fanny ^a,b   Hong, Saw See ^c   Le Naour, Richard ^b   Gafa, Valérie ^b   Talmud, Déborah ^a,b   Andréoletti, Laurent ^a,b   Lévêque, Nicolas ^a,b  

^a REIMS UNIVERSITY HOSPITAL   (France)

^b UNIVERSITÉ DE REIMS CHAMPAGNE ARDENNE   (France)

^c UNIVERSITÉ LYON 1   (France)

Author keywords

Coxsackie adenovirus receptor; Decay accelerating factor; Echovirus 6; Haemagglutinating strain; Receptors; Virus attachment; Virus entry

Indexed keywords

COMPLEMENTARY DNA; COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR; DECAY ACCELERATING FACTOR; MESSENGER RNA; PROTEIN VP1; VIRUS RNA;

ANIMAL CELL; ARTICLE; CELL ADHESION; CHO CELL; CONTROLLED STUDY; ECHO VIRUS; ECHOVIRUS INFECTION; GENE EXPRESSION; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STABLE TRANSFECTION; VIRUS ATTACHMENT; VIRUS ENTRY; VIRUS LOAD; VIRUS PARTICLE; VIRUS PATHOGENESIS; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; ANTIGENS, CD55; CHO CELLS; CRICETINAE; CRICETULUS; ECHOVIRUS 6, HUMAN; HUMANS; RECEPTORS, VIRUS; VIRUS INTERNALIZATION;

ADENOVIRIDAE; CRICETULUS GRISEUS; HUMAN ECHOVIRUS 6;

EID: 79956305911     PISSN: 01681702     EISSN: 18727492     Source Type: Journal    
DOI: 10.1016/j.virusres.2011.03.009     Document Type: Article

References (46)

1. Abe O., Kimura H., Minakami H., Akami M., Inoue M., Saito A., Otsuki K. Outbreak of gastroenteritis caused by echovirus type 6 in an orphanage in Japan. J. Infect. 2000, 41(3):285-286.
2. Agrez M.V., Shafren D.R., Gu X., Cox K., Sheppard D., Barry R.D. Integrin alpha v beta 6 enhances coxsackievirus B1 lytic infection of human colon cancer cells. Virology 1997, 239(1):71-77.
3. Antona D., Lévêque N., Chomel J.J., Dubrou S., Lévy-Bruhl D., Lina B. Surveillance of enteroviruses in France, 2000-2004. Eur. J. Clin. Microbiol. Infect. Dis. 2007, 26(6):403-412.
4. Bergelson J.M., Shepley M.P., Chan B.M., Hemler M.E., Finberg R.W. Identification of the integrin VLA-2 as a receptor for echovirus 1. Science 1992, 255(5052):1718-1720.
5. Bergelson J.M., St John N., Kawaguchi S., Chan M., Stubdal H., Modlin J., Finberg R.W. Infection by echoviruses 1 and 8 depends on the alpha 2 subunit of human VLA-2. J. Virol. 1993, 67(11):6847-6852.
6. Bergelson J.M., Chan M., Solomon K.R., St John N.F., Lin H., Finberg R.W. Decay-accelerating factor (CD55), a glycosylphosphatidylinositol-anchored complement regulatory protein, is a receptor for several echoviruses. Proc. Natl. Acad. Sci. U.S.A. 1994, 91(13):6245-6248.
7. Bergelson J.M., Mohanty J.G., Crowell R.L., St John N.F., Lublin D.M., Finberg R.W. Coxsackievirus B3 adapted to growth in RD cells binds to decay-accelerating factor (CD55). J. Virol. 1995, 69(3):1903-1906.
8. Bergelson J.M., Cunningham J.A., Droguett G., Kurt-Jones E.A., Krithivas A., Hong J.S., Horwitz M.S., Crowell R.L., Finberg R.W. Isolation of a common receptor for Coxsackie B viruses and adenoviruses 2 and 5. Science 1997, 275(5304):1320-1323.
9. Berger M.M., Kopp N., Vital C., Redl B., Aymard M., Lina B. Detection and cellular localization of enterovirus RNA sequences in spinal cord of patients with ALS. Neurology 2000, 54(1):20-25.
10. Brodbeck W.G., Kuttner-Kondo L., Mold C., Medof M.E. Structure/function studies of human decay-accelerating factor. Immunology 2000, 101(1):104-111.
11. Chevaliez S., Balanant J., Maillard P., Lone Y.-C., Lemonnier F.A., Delpeyroux F. Role of class I human leukocyte antigen molecules in early steps of echovirus infection of rhabdomyosarcoma cells. Virology 2008, 381(2):203-214.
12. Chomel J.J., Antona D., Thouvenot D., Lina B. Three ECHOvirus serotypes responsible for outbreak of aseptic meningitis in Rhône-Alpes region, France. Eur. J. Clin. Microbiol. Infect. Dis. 2003, 22(3):191-193.
13. Clarkson N.A., Kaufman R., Lublin D.M., Ward T., Pipkin P.A., Minor P.D., Evans D.J., Almond J.W. Characterization of the echovirus 7 receptor: domains of CD55 critical for virus binding. J. Virol. 1995, 69(9):5497-5501.
14. Cova L., Aymard M. Isolation and characterization of non-haemagglutinating echoviorus 11. J. Gen. Virol. 1980, 51(Pt 1):219-222.
15. Coyne C.B., Bergelson J.M. Virus-induced Abl and Fyn kinase signals permit coxsackievirus entry through epithelial tight junctions. Cell 2006, 124(1):119-131.
16. Domingo E., Martin V., Perales C., Escarmis C. Coxsackieviruses and quasispecies theory: evolution of enteroviruses. Curr. Top. Microbiol. Immunol. 2008, 323:32-33.
17. Goodfellow I.G., Powell R.M., Ward T., Spiller O.B., Almond J.W., Evans D.J. Echovirus infection of rhabdomyosarcoma cells is inhibited by antiserum to the complement control protein CD59. J. Gen. Virol. 2000, 81(Pt 5):1393-1401.
18. Goodfellow I.G., Sioofy A.B., Powell R.M., Evans D.J. Echoviruses bind heparan sulfate at the cell surface. J. Virol. 2001, 75(10):4918-4921.
19. Hafenstein S., Bowman V.D., Chipman P.R., Bator Kelly C.M., Lin F., Medof M.E., Rossmann M.G. Interaction of decay-accelerating factor with coxsackievirus B3. J. Virol. 2007, 81(23):12927-12935.
20. Heikkilä O., Susi P., Stanway G., Hyypiä T. Integrin alphaVbeta6 is a high-affinity receptor for coxsackievirus A9. J. Gen. Virol. 2009, 90(Pt 1):197-204.
21. Jokinen J., White D.J., Salmela M., Huhtala M., Käpylä J., Sipilä K., Puranen J.S., Nissinen L., Kankaanpää P., Marjomäki V., Hyypiä T., Johnson M.S., Heino J. Molecular mechanism of alpha2beta1 integrin interaction with human echovirus 1. EMBO J. 2010, 29(1):196-208.
22. Karnauchow T.M., Tolson D.L., Harrison B.A., Altman E., Lublin D.M., Dimock K. The HeLa cell receptor for enterovirus 70 is decay-accelerating factor (CD55). J. Virol. 1996, 70(8):5143-5152.
23. Lévêque N., Norder H., Zreik Y., Cartet G., Falcon D., Rivat N., Chomel J.J., Hong S.S., Lina B. Echovirus 6 strains derived from a clinical isolate show differences in haemagglutination ability and cell entry pathway. Virus Res. 2007, 130(1/2):1-9.
24. Lozahic S., Christiansen D., Manié S., Gerlier D., Billard M., Boucheix C., Rubinstein E. CD46 (membrane cofactor protein) associates with multiple beta1 integrins and tetraspans. Eur. J. Immunol. 2000, 30(3):900-907.
25. Lublin D.M., Atkinson J.P. Decay-accelerating factor: biochemistry, molecular biology, and function. Annu. Rev. Immunol. 1989, 7:35-58.
26. Lublin D.M., Coyne K.E. Phospholipid-anchored and transmembrane versions of either decay-accelerating factor or membrane cofactor protein show equal efficiency in protection from complement-mediated cell damage. J. Exp. Med. 1991, 174(1):35-44.
27. Lukashev A.N., Ivanova O.E., Eremeeva T.P., Gmyl L.V. Analysis of echovirus 30 isolates from Russia and new independent states revealing frequent recombination and reemergence of ancient lineages. J. Clin. Microbiol. 2008, 46(2):665-670.
28. Medof M.E., Kinoshita T., Nussenzweig V. Inhibition of complement activation on the surface of cells after incorporation of decay-accelerating factor (DAF) into their membranes. J. Exp. Med. 1984, 160(5):1558-1578.
29. Milstone A.M., Petrella J., Sanchez M.D., Mahmud M., Whitbeck J.C., Bergelson J.M. Interaction with coxsackievirus and adenovirus receptor, but not with decay-accelerating factor (DAF), induces A-particle formation in a DAF-binding coxsackievirus B3 isolate. J. Virol. 2005, 79(1):655-660.
30. Mirand A., Henquell C., Archimbaud C., Peigue-Lafeuille H., Bailly J.L. Emergence of recent echovirus 30 lineages is marked by serial genetic recombination events. J. Gen. Virol. 2007, 88(Pt 1):166-176.
31. Nilsson E.C., Jamshidi F., Johansson S.M.C., Oberste M.S., Arnberg N. Sialic acid is a cellular receptor for coxsackievirus A24 variant, an emerging virus with pandemic potential. J. Virol. 2008, 82(6):3061-3068.
32. Pasch A., Küpper J.H., Wolde A., Kandolf R., Selinka H.C. Comparative analysis of virus-host cell interactions of haemagglutinating and non-haemagglutinating strains of coxsackievirus B3. J. Gen. Virol. 1999, 80(Pt 12):3153-3158.
33. Pfeiffer J.K., Kirkegaard K. Bottleneck-mediated quasispecies restriction during spread of an RNA virus from inoculation site to brain. Proc. Natl. Acad. Sci. U.S.A. 2006, 103(14):5520-5525.
34. Powell R.M., Ward T., Evans D.J., Almond J.W. Interaction between echovirus 7 and its receptor, decay-accelerating factor (CD55): evidence for a secondary cellular factor in A-particle formation. J. Virol. 1997, 71(12):9306-9312.
35. Powell R.M., Schmitt V., Ward T., Goodfellow I., Evans D.J., Almond J.W. Characterization of echoviruses that bind decay accelerating factor (CD55): evidence that some haemagglutinating strains use more than one cellular receptor. J. Gen. Virol. 1998, 79(Pt 7):1707-1713.
36. Racaniello V.R. Picornaviridae: the viruses and their replication. Fields Virology 2007, vol. 1:795-838. Lippincott, Williams and Wilkins, Philadelphia, 2 vols. fifth edition.
37. Reagan K.J., Goldberg B., Crowell R.L. Altered receptor specificity of coxsackievirus B3 after growth in rhabdomyosarcoma cells. J. Virol. 1984, 49:635-640.
38. Rezaikin A.V., Novoselov A.V., Sergeev A.G., Fadeyev F.A., Lebedev S.V. Two clusters of mutations map distinct receptor-binding sites of echovirus 11 for the decay-accelerating factor (CD55) and for canyon-binding receptors. Virus Res. 2009, 145(1):74-79.
39. Roivainen M., Piirainen L., Hovi T., Virtanen I., Riikonen T., Heino J., Hyypiä T. Entry of coxsackievirus A9 into host cells: specific interactions with alpha v beta 3 integrin, the vitronectin receptor. Virology 1994, 203(2):357-365.
40. Shafren D.R., Bates R.C., Agrez M.V., Herd R.L., Burns G.F., Barry R.D. Coxsackieviruses B1 B3, and B5 use decay accelerating factor as a receptor for cell attachment. J. Virol. 1995, 69(6):3873-3877.
41. Shafren D.R., Dorahy D.J., Ingham R.A., Burns G.F., Barry R.D. Coxsackievirus A21 binds to decay-accelerating factor but requires intercellular adhesion molecule 1 for cell entry. J. Virol. 1997, 71(6):4736-4743.
42. Ventura K.C., Hawkins H., Smith M.B., Walker D.H. Fatal neonatal echovirus 6 infection: autopsy case report and review of the literature. Mod. Pathol. 2001, 14(2):85-90.
43. Vignuzzi M., Stone J.K., Arnold J.J., Cameron C.E., Andino R. Quasispecies diversity determines pathogenesis through cooperative interactions in a viral population. Nature 2006, 439(7074):344-348.
44. Ward T., Pipkin P.A., Clarkson N.A., Stone D.M., Minor P.D., Almond J.W. Decay-accelerating factor CD55 is identified as the receptor for echovirus 7 using CELICS, a rapid immuno-focal cloning method. EMBO J. 1994, 13(21):5070-5074.
45. Ward T., Powell R.M., Pipkin P.A., Evans D.J., Minor P.D., Almond J.W. Role for beta2-microglobulin in echovirus infection of rhabdomyosarcoma cells. J. Virol. 1998, 72(7):5360-5365.
46. Zoll G.J., Melchers W.J., Kopecka H., Jambroes G., van der Poel H.J., Galama J.M. General primer-mediated polymerase chain reaction for detection of enteroviruses: application for diagnostic routine and persistent infections. J. Clin. Microbiol. 1992, 30(1):160-165.